Category: Zacks Small Cap Research
By Brian Marckx, CFAOTC:SMLRREAD THE FULL SMLR RESEARCH REPORTOn June 17th, Semler (OTC:SMLR) announced that while CEO Doug Murphy-Chutorian suffered a mild stroke following elective surgery, he continues to lead the company and the incident did not ...
By David Bautz, PhDTSX:MDNA.TO | OTC:MDNAFREAD THE FULL MDNA.TO RESEARCH REPORTBusiness UpdateOn June 18, 2019, Medicenna Therapeutics Corp. (TSX:MDNA) (OTC:MDNAF) announced the presentation of preliminary topline results from the company’s ongoing P ...
By John Vandermosten, CFANYSE:CVMIn late May 2019, Zacks was treated to an onsite tour of CEL-SCI’s (NYSE:CVM) 73,000 square foot manufacturing facility in Elkridge, Maryland. As we drove to the industrial park southwest of Baltimore, we came upon CE ...
By Ann Heffron, CFA, CPAOTC:CPKFREAD THE FULL CPKF RESEARCH REPORTChesapeake Financial's (OTC:CPKF) first quarter net earnings rose $0.2 million, or 2%, year over year to $3.0 million, while 2019’s first quarter diluted EPS increased by $0.02, or 2%, ...
By M. MarinOTC:VQSLF | TSX:VQSREAD THE FULL VQSLF RESEARCH REPORTVIQ Solutions (OTC:VQSLF) (TSX:VQS) operates a secure technology platform that offers artificial intelligence (AI) enabled video capture software and audio recording with voice-to-text ...
By Brian Marckx, CFANASDAQ:MNKDREAD THE FULL MNKD RESEARCH REPORTNew data from three different studies of Afrezza was announced at the American Diabetes Association’s 79th Scientific Sessions (June 7 – 11) in San Francisco. This includes safety and P ...
By Lisa ThompsonNYSE:DSSREAD THE FULL DSS RESEARCH REPORTDocument Security Systems, Inc. (NYSE:DSS) has long been afflicted with not having enough resources to pursue growth and this past quarter the company took actions to address longer term needs ...
By David Bautz, PhDNASDAQ:BVXVREAD THE FULL BVXV RESEARCH REPORTFinancial UpdateOn May 30, 2019, BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) announced financial results for the first quarter of 2019. As expected, the company did not report any revenu ...
By John Vandermosten, CFANASDAQ:HTBXREAD THE FULL HTBX RESEARCH REPORTFirst Quarter 2019 Results Heat Biologics, Inc. (NASDAQ:HTBX) reported first quarter 2019 results in a May 15 release and concurrently submitted the companion 10-Q to the SEC. Sinc ...
By John Vandermosten, CFANASDAQ:ACHVAchieve Life Sciences, Inc. (NASDAQ:ACHV) reported topline results from its Phase IIb Ongoing Research of Cytisinicline for Addiction (ORCA)-1 trial which was launched in October 2018. The study enrolled 254 subjec ...